Tesamorelin + CJC-1295 (no DAC) + Ipamorelin

The Tesamorelin + CJC-1295 (no DAC) + Ipamorelin blend functions by stimulating the release of growth hormone through different mechanisms. Tesamorelin is a synthetic peptide that mimics the natural growth hormone-releasing hormone (GHRH), which originates from the hypothalamus. CJC-1295 (no DAC), also a GHRH analog, enhances growth hormone secretion over extended periods without the DAC modification. Ipamorelin, a selective ghrelin receptor agonist, promotes growth hormone release with minimal effect on cortisol levels. Research into this peptide blend began as scientists sought to explore new avenues for modulating growth hormone levels, driven by the interest in addressing growth disorders and aging-related conditions. Early studies provided insight into the potential applications of these peptides in various fields. Today, it is primarily studied for its effects on:

• Increasing growth hormone levels
• Investigating aging processes
• Studying body composition
• Analyzing metabolic effects
• Exploring neuroendocrine interactions

The combination of these peptides provides a multi-faceted approach to growth hormone stimulation, appealing to researchers interested in endocrine modulation.

PeptideSource editorial · Updated Jul 18, 2026